INTRECOM
Company

INTRECOM

Biotechnology Research 31 employees
Employees
31

INTRECOM Overview

Industry
Biotechnology Research
Employees
31
Founded
2022
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About INTRECOM

Patients with Locked-In Syndrome (LIS) are completely paralysed and unable to communicate. This is an intolerable, fearful situation with very low quality of life and extreme burden of care for patients, family, and care givers. INTRECOM will provide a breakthrough for these patients by developing a novel, fully implantable Brain-Computer Interface (BCI) technology that allows for real-time speech decoding and use in the home environment. This BCI system will significantly transcend current technology by providing a high-resolution and sustainable device, combining state-of-the-art hardware and software solutions based on Artificial Intelligence (AI) to liberate LIS patients from their isolation.

Compare Similar Companies to INTRECOM